SK6942003A3 - Oral extended release formulation of gepirone - Google Patents

Oral extended release formulation of gepirone Download PDF

Info

Publication number
SK6942003A3
SK6942003A3 SK694-2003A SK6942003A SK6942003A3 SK 6942003 A3 SK6942003 A3 SK 6942003A3 SK 6942003 A SK6942003 A SK 6942003A SK 6942003 A3 SK6942003 A3 SK 6942003A3
Authority
SK
Slovakia
Prior art keywords
amount
gepirone
pharmaceutical composition
tablets
polymer matrix
Prior art date
Application number
SK694-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Johannes Gerardus Jos Egberink
John Francis Engelhart
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of SK6942003A3 publication Critical patent/SK6942003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK694-2003A 2000-12-08 2001-11-30 Oral extended release formulation of gepirone SK6942003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204388 2000-12-08
PCT/EP2001/014189 WO2002045753A2 (en) 2000-12-08 2001-11-30 Oral extended release formulation of gepirone

Publications (1)

Publication Number Publication Date
SK6942003A3 true SK6942003A3 (en) 2003-10-07

Family

ID=8172397

Family Applications (1)

Application Number Title Priority Date Filing Date
SK694-2003A SK6942003A3 (en) 2000-12-08 2001-11-30 Oral extended release formulation of gepirone

Country Status (19)

Country Link
EP (1) EP1343504A2 (hu)
JP (1) JP2004517083A (hu)
KR (1) KR20040018314A (hu)
CN (1) CN1479620A (hu)
AR (1) AR031461A1 (hu)
AU (1) AU2002226371A1 (hu)
BR (1) BR0115976A (hu)
CA (1) CA2436692A1 (hu)
CZ (1) CZ20031589A3 (hu)
EC (1) ECSP034627A (hu)
HU (1) HUP0401021A2 (hu)
IL (1) IL155855A0 (hu)
MX (1) MXPA03005099A (hu)
NO (1) NO20032581L (hu)
PL (1) PL362445A1 (hu)
RU (1) RU2003120446A (hu)
SK (1) SK6942003A3 (hu)
WO (1) WO2002045753A2 (hu)
ZA (1) ZA200303915B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545469A1 (en) * 2002-09-24 2005-06-29 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
BRPI0419179A (pt) * 2004-11-05 2007-12-18 Fabre Kramer Pharmaceuticals I formulação de alta dosagem de liberação prolongada de gepirona
MY198454A (en) * 2017-07-26 2023-08-29 Abbott Lab Nutritional Tablets and Methods of Making the Same
CN109745323A (zh) * 2017-11-01 2019-05-14 四川科瑞德制药股份有限公司 氮哌酮类化合物提高副交感神经活性的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form

Also Published As

Publication number Publication date
KR20040018314A (ko) 2004-03-03
AR031461A1 (es) 2003-09-24
NO20032581D0 (no) 2003-06-06
HUP0401021A2 (hu) 2004-09-28
EP1343504A2 (en) 2003-09-17
WO2002045753A2 (en) 2002-06-13
JP2004517083A (ja) 2004-06-10
ECSP034627A (es) 2004-09-28
CN1479620A (zh) 2004-03-03
PL362445A1 (en) 2004-11-02
CZ20031589A3 (cs) 2003-11-12
ZA200303915B (en) 2004-08-20
RU2003120446A (ru) 2005-02-20
IL155855A0 (en) 2003-12-23
AU2002226371A1 (en) 2002-06-18
NO20032581L (no) 2003-06-06
MXPA03005099A (es) 2004-02-12
BR0115976A (pt) 2003-12-30
WO2002045753A3 (en) 2002-08-29
CA2436692A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
EP0914119B1 (en) Process for forming solid oral dosage forms of valsartan
US6103263A (en) Delayed pulse release hydrogel matrix tablet
US20110177168A1 (en) Composition
US20110071137A1 (en) Process for preparing sustained release tablets
NZ279648A (en) Controlled release tablet comprising a drug, a hydrogelling agent and an ionizable compound to provide a zero-order release rate of the drug
EP1646374A1 (en) Extended-release tablets of metformin
KR20010086062A (ko) 고가용성 약물용 서방성 메트리스 시스템
US20110196032A1 (en) Pharmaceutical Dosage Form of an Antidepressant
US20030104059A1 (en) Controlled release tablets of metformin
DE4310963A1 (de) Retardtablette von beta-Phenylpropiophenonderivaten
CA2493593A1 (en) Bicifadine formulation
US11878078B2 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
SK6942003A3 (en) Oral extended release formulation of gepirone
WO2005092293A1 (en) Formulations of metformin
US20050271718A1 (en) Sustained release propafenone hydrochloride capsules
US20040213843A1 (en) Pharmaceutical formulation of gepirone for oral administration
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami
US20070087055A1 (en) Directly compressible extended release alprazolam formulation
CN1476841A (zh) 葛根素分散片组合物及其制备方法
AU2007201830B2 (en) High drug load tablet
KR20050010843A (ko) 활성 성분을 지속 방출시키는, 옥스카바제핀 함유약제학적 조성물